Protection from radiation-induced chromosomal aberrations by the nitroxide Tempol

Area of Science:

• Radiation biology
• Cellular toxicology
• Genetics

Background:

• Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) is a stable free radical with known radioprotective and antioxidant properties.
• Previous studies indicate Tempol protects against oxidative stress and radiation damage in various models.
• Understanding Tempol's mechanism in mitigating radiation-induced genetic damage is crucial.

Purpose of the Study:

• To investigate the radioprotective effects of Tempol on human peripheral blood lymphocytes (PBLs).
• To evaluate Tempol's ability to prevent radiation-induced chromosomal aberrations.
• To elucidate the role of Tempol in mitigating DNA damage post-irradiation.

Main Methods:

• Human PBLs were pre-treated with varying concentrations of Tempol (10 mM and 50 mM) prior to exposure to different doses of ionizing radiation (0-450 cGy).
• Cells were cultured and harvested at specific time points (49-64 hours) to assess chromosomal damage.
• Mitotic indices and frequencies of dicentric, ring, and triradial aberrations were quantified under microscopy.

Main Results:

• Tempol treatment alone did not increase chromosomal aberration rates compared to controls.
• Tempol demonstrated significant radioprotection, reducing the frequency of radiation-induced chromosomal aberrations in a dose-dependent manner.
• Protection factors for 10 mM and 50 mM Tempol were calculated as 2.2 and 2.8, respectively.

Conclusions:

• Tempol effectively protects human PBLs against radiation-induced chromosomal aberrations.
• These findings support previous research on Tempol's role in enhancing cell survival and reducing DNA double-strand breaks.
• Tempol shows promise as a radioprotective agent for mitigating radiation-induced genetic damage.